Digital Health Global

NOVEMBER 30, 2023

Digital Health Technologies ( DHTs ) have revolutionized the landscape of clinical trials, particularly in neurology research, by enabling the collection of real-world data outside traditional clinical settings. It has been used in various studies in Europe with great results.

Health Technology 157

Health Technology Digital Health Life Science BioTech 157

Digital Health Global

JANUARY 4, 2024

Koneksa’s innovative digital model aims to address limitations in existing functional status assessments by leveraging digital health technologies (DHTs) for both objective and self-reported outcomes. Up to 25 patients will be enrolled in this clinical validation study of 24/7 functional status in orthopedics (hip replacements).

Health Technology 88

Health Technology Digital Health Drug Development healthcare technology 88

Digital Health Global

APRIL 25, 2024

The study, led by principal investigator Nitin Ohri, M.D., The study, led by principal investigator Nitin Ohri, M.D., This pilot study represents a critical step in leveraging digital health technology to enhance cancer treatment outcomes,” said John Wagner, M.D., Chief Medical Officer, Koneksa. “By

Health Data 88

Health Data BioTech Drug Development healthcare technology 88

Digital Health Global

MARCH 26, 2024

BASEL, Switzerland–(BUSINESS WIRE)–Indivi, a leading MedTech company headquartered in Basel, Switzerland, has entered into an agreement with Biogen to advance digital health technology and develop digital biomarkers for Parkinson’s disease.

Health Technology 88

Health Technology Digital Health BioTech Drug Development 88

Digital Health Global

JUNE 13, 2023

The LEARNS study will investigate the Koneksa neuroscience solution, as well as the Beacon Biosignals platform, applied to at-home EEG, compared with in-clinic polysomnography, in neurological and sleep disorders. Beacon’s mobile EEG will join more than a dozen digital health technologies that are already integrated into the Koneksa solution.

Drug Development 88

Drug Development eMed BioTech Digital Health 88

Digital Health Global

NOVEMBER 20, 2023

We believe Evinova’s combination of scientific expertise and track record in developing AI-enabled digital technologies at scale, provides a real opportunity to fundamentally improve patient care, drive healthcare transformation and reduce carbon emissions.” Site interaction is available through a single-sign-on portal.

Life Science 88

Life Science Digital Health Drug Development Patient Experience 88

Digital Health Global

APRIL 5, 2024

Furthermore, the industry witnessed a decline in the average return on investment (ROI) for R&D to as low as 1.2%, and the peak sales per asset valued just above $350 million, indicating a need to build more efficient drug development processes with the implementation of newer technologies.

Drug Development 88

Drug Development Pharmaceuticals Digital Health Health Technology 88